维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

15篇 您的检索式：作者名="Emser"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Treatment options in childhood pontine gliomas 显示文摘	Wagner S Warmuth-Metz M Emser A	2006	J Neurooncol2006，79，3：	1
	2	Survival andprognostic factors of early childhood medulloblastoma ; aninternational meta-analysis显示文摘	Rutkowski S von Hoff K Emser A	2010	J Clin Oncol2010，28，33：	1
	3	Safety and tolerability of linagliptia:a pooled analysis of data from randomized controlled trials in 3752 patients with type2diabetes mcllitus 显示文摘	Schernthaner G Barnett AH Emser A	2012	Diabetes Obes Metab2012，14，5：	1
	4	Renal impairment has no relevant effect on long- term exposure of linagliptin in patients with type 2 diabetes mellitus显示文摘	FRIEDRICH C EMSER A WOERLE HJ	2011	Diabetes2011，601，：	1
	5	Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and eardiovaseular disease: a pooled analysis of six phase III clinical trials显示文摘	Maximilian von Eynatten Yan Gong Angela Emser	2013	Cardio Diab2013，12，：	1
	6	Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus 显示文摘	Schernthaner G Barnett AH Emser A	2012	Diab Obes Metab2012，14，：	1
	7	Survival and prognostic factors of early childhood medulloblastoma : an international meta- analysis显示文摘	Rutkowski S yon HK Emser A	2010	J Clin Oncol2010，28，33：	1
	8	Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus显示文摘	SCHERNTHANER G BARNETT AH EMSER A	2012	Diabetes Obes Metab2012，14，5：	1
	9	Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease: a pooled analysis of six phase III clinical trials显示文摘	von Eynatten M Gong Y Emser A	2013	Cardiovasc Diabetol2013，12，：	1
	10	Safty and tolerability of linagliptin:a pooled analysis of data from randomized controlled trials in 3572 patients with 2 diabetes mellit-us显示文摘	Schernthaner G Barnett A H Emser A		0，，5：	1
	11	Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: pooled analysis of data from three placebo-controlled Phase III trials显示文摘	Stefano Del Prato Marja-Riitta Taskinen David R. Owens Maximilian von Eynatten Angela Emser Yan Gong Silvia Chiavetta Sanjay Patel Hans-Juergen Woerle	2012	Journal of Diabetes and Its Complications2012，，：	1
	12	Efficacy and safety of linagliptin in type 2 diabetes subjects at high risk for renal and cardiovascular disease:a pooled analysis of six phase III clinical trials 显示文摘	yon Eynatten M Gong Y Emser A	2013	Cardio Diab2013，12，：	1
	13	Safety and tolerability of linagliptin: a pooled analysis of data from randomized controlled trials in 3572 patients with type 2 diabetes mellitus 显示文摘	SCHERNTHANER G BARNETT A H EMSER A	2012	Diabetes Obes Metab2012，14，5：	1
	14	Linagliptin Lowers Albuminuria on Top of Recommended Standard Treatment in Patients With Type 2 Diabetes and Renal Dysfunction显示文摘	Per-Henrik Groop Mark E. Cooper Vlado Perkovic Angela Emser Hans-Juergen Woerle Maximilian von Eynatten	2013	Diabetes Care2013，，11：	1
	15	Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis显示文摘	Rutkowski S von Hoff K Emser A	2010	J Clin Oncol2010，28，33：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费